2008
DOI: 10.1016/j.ajhg.2007.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Sequence Alterations within CYP7B1 Implicate Defective Cholesterol Homeostasis in Motor-Neuron Degeneration

Abstract: The hereditary spastic paraplegias (HSPs) are a genetically and clinically heterogeneous group of upper-motor-neuron degenerative diseases characterized by selective axonal loss in the corticospinal tracts and dorsal columns. Although numerous mechanisms involving defective subcellular transportation, mitochondrial malfunction, and increased oxidative stress have been proposed, the pathogenic basis underlying the neuronal loss is unknown. We have performed linkage analysis to refine the extent of the SPG5 dise… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
92
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 165 publications
(98 citation statements)
references
References 33 publications
5
92
0
Order By: Relevance
“…This was the case for SPG7 (paraplegin) and SPG5 (CYB7B1). 16,17,22,23 In terms of disease progression, SPG30 differs from other ARHSPs, such as SPG11, 24 in having a less severe evolution, as all affected members were still able to walk after disease durations of between 9 and 22 years even if maximal walking distance was reduced in all patients.…”
Section: Spg30 Phenotypementioning
confidence: 95%
“…This was the case for SPG7 (paraplegin) and SPG5 (CYB7B1). 16,17,22,23 In terms of disease progression, SPG30 differs from other ARHSPs, such as SPG11, 24 in having a less severe evolution, as all affected members were still able to walk after disease durations of between 9 and 22 years even if maximal walking distance was reduced in all patients.…”
Section: Spg30 Phenotypementioning
confidence: 95%
“…The proband had definite HSP with disease onset at the age of seven, and some sensory involvement and seizures. A homozygous c.1450G>A mutation was previously reported in a Tunisian consanguineous family 2 and as a compound heterozygous state in a French sporadic case 4 . The second case was an unrelated French Canadian family (Figure, Family B), both the HSP proband and her affected brother had compound heterozygous mutations in CYP7B1.…”
Section: Resultsmentioning
confidence: 99%
“…Many HSP families have been mapped to this particular locus and the causative gene was finally identified in 2008. Mutations in Cytochrome P450, family 7, subfamily B polypeptide 1 (CYP7B1) gene were then found to underlie this particular disorder; homozygous mutations were originally identified in a consanguineous English family 2 . CYP7B1 extends over~220 Kb gene and contain six exons that encode for an evolutionarily conserved steroid metabolizing enzyme, cytochrome P450.…”
mentioning
confidence: 99%
“…This enzyme has been associated with several physiological processes, including brain function, immune system, cholesterol homeostasis and cellular viability and growth. Scientific publications in various areas have linked altered CYP7B1 levels and/or function to neurodegenerative processes, arthritis, and prostate cancer (Dulos et al, 2004;Olsson et al, 2007;Tsaousidou et al, 2008;Yau et al, 2003). However, the manner in which CYP7B1 affects these processes are in many cases unclear.…”
Section: Actions Of Cyp7b1 -Potential Role(s) For the Levels And Effementioning
confidence: 99%